Dealings in securities by directors
ASCENDIS HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2008/005856/06)
ISIN: ZAE000185005 Share code: ASC
(“Ascendis”)
Dealings in securities by directors
In terms of paragraphs 3.63 to 3.65 of the JSE Limited (“the JSE”) Listings Requirements ("the Listings
Requirements"), the following information, relating to dealings in securities by directors, is disclosed:
Directors: Gary Shayne and Crispian Dillon
Nature of the transaction: Ascendis has entered into an agreement (which
remains subject to certain conditions precedent) to
acquire the remaining shareholding not yet owned by
Ascendis in a company operating in the
pharmaceutical industry (“Target”), and which is less
than a category two transaction in terms of the
Listings Requirements i.e. less than 5% of the issued
share capital and/or market capitalisation of Ascendis.
The latest practicable date for completion of all
outstanding conditions precedent pertaining to the
acquisition of the Target is 16 October 2015 (“Closing
Date”). In this transaction the purchase consideration
will be paid via Ascendis delivering 266,667 Ascendis
shares to the disposing shareholder of the Target
(“Disposing Shareholder”). These shares will be
sourced from Ascendis’ existing treasury shares and
in terms of the Listings Requirements will be treated
as a fresh issue of shares in terms of para 5.75.
Gane Holdings Proprietary Limited (“Gane Holdings”),
which does not form part of the Ascendis group of
companies, has entered into a separate agreement
(“Option Agreement”) with the Disposing Shareholder,
dated 21 May 2015, whereby Gane Holdings has
granted the Disposing Shareholder a put option and
the Disposing Shareholder has granted Gane
Holdings a reciprocal Call Option in respect of
266,667 Ascendis ordinary shares (“Option Shares”)
at a future date (“Option Trigger Date”).
Permission was granted by the Ascendis board of
directors, excluding Gary Shayne and Cris Dillon (“the
Board”), for Gane Holdings to enter into the Option
Agreement.
No fees are payable by Ascendis to Gane Holdings for
this agreement and there are thus no financial
implications for Ascendis as a result of this
agreement.
Option Trigger Date: Within 60 business days commencing on the second
anniversary of the Closing Date.
Strike price Not applicable
Number of shares: 266,667
Purchase price per share: R21.00
Value: R5,600,007.00
Date of transaction: 21 May 2015
Class of shares: Ordinary shares
Extent of interest: Indirect beneficial (through Gane Holdings, in which
Gary Shayne has a 85% indirect beneficial interest
and Crispian Dillon has a 15% indirect beneficial
interest).
Written clearance obtained: Clearance was obtained from the Chairman.
22 May 2015
Johannesburg
Sponsor
Investec Bank Limited
Date: 22/05/2015 09:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.